Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
LivaNova PLC - Ordinary Shares
(NQ:
LIVN
)
71.85
+0.92 (+1.30%)
Streaming Delayed Price
Updated: 3:57 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about LivaNova PLC - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
LivaNova (LIVN) Q1 2025 Earnings Transcript
↗
May 07, 2026
LivaNova (LIVN) Q1 2025 Earnings Transcript
Via
The Motley Fool
LivaNova (LIVN) Q2 2025 Earnings Transcript
↗
May 06, 2026
LivaNova (LIVN) Q2 2025 Earnings Transcript
Via
The Motley Fool
Topics
Supply Chain
LivaNova (LIVN) Q3 2025 Earnings Transcript
↗
May 06, 2026
LivaNova (LIVN) Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
World Trade
LivaNova PLC (NASDAQ:LIVN) Beats Q1 Estimates, Lifts Full-Year Guidance
↗
May 06, 2026
Via
Chartmill
LivaNova (NASDAQ:LIVN) Beats Q4 Estimates, Provides Steady 2026 Outlook
↗
February 25, 2026
Via
Chartmill
LivaNova (LIVN) Q1 2026 Earnings Transcript
↗
May 06, 2026
LivaNova (LIVN) Q1 2026 Earnings Transcript
Via
The Motley Fool
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
May 06, 2026
From
LivaNova PLC
Via
Business Wire
Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
April 20, 2026
From
LivaNova PLC
Via
Business Wire
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
LivaNova to Announce First-Quarter 2026 Results
March 25, 2026
From
LivaNova PLC
Via
Business Wire
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
March 19, 2026
From
LivaNova PLC
Via
Business Wire
LivaNova (LIVN) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
LivaNova (LIVN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
February 25, 2026
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
January 20, 2026
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at J.P. Morgan Healthcare Conference in January
December 23, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
December 03, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
December 02, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Piper Sandler Healthcare Conference in December
November 25, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
November 24, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
November 12, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova PLC (NASDAQ:LIVN) Beats Q3 2025 Estimates and Raises Full-Year Guidance
↗
November 05, 2025
LivaNova (LIVN) beat Q3 2025 earnings and revenue estimates, raising its full-year guidance on strong performance across its Cardiopulmonary and Neuromodulation segments.
Via
Chartmill
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
November 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Wolfe Research Healthcare Conference in November
October 23, 2025
From
LivaNova PLC
Via
Business Wire
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
October 13, 2025
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the...
Via
MarketMinute
LivaNova to Announce Third-Quarter 2025 Results
October 08, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
October 07, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Appoints Donald Zurbay as a New Director
September 04, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Host Investor Day on November 12, 2025
August 25, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
August 22, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Launches Essenz Perfusion System in China
August 18, 2025
From
LivaNova PLC
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
